BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12215553)

  • 1. The FDG lumped constant in normal human brain.
    Graham MM; Muzi M; Spence AM; O'Sullivan F; Lewellen TK; Link JM; Krohn KA
    J Nucl Med; 2002 Sep; 43(9):1157-66. PubMed ID: 12215553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]glucose and FDG: analysis of the FDG lumped constant.
    Spence AM; Muzi M; Graham MM; O'Sullivan F; Krohn KA; Link JM; Lewellen TK; Lewellen B; Freeman SD; Berger MS; Ojemann GA
    J Nucl Med; 1998 Mar; 39(3):440-8. PubMed ID: 9529289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absolute quantification of regional cerebral glucose utilization in mice by 18F-FDG small animal PET scanning and 2-14C-DG autoradiography.
    Toyama H; Ichise M; Liow JS; Modell KJ; Vines DC; Esaki T; Cook M; Seidel J; Sokoloff L; Green MV; Innis RB
    J Nucl Med; 2004 Aug; 45(8):1398-405. PubMed ID: 15299067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Operational lumped constant for FDG in normal adult male rats.
    Tokugawa J; Ravasi L; Nakayama T; Schmidt KC; Sokoloff L
    J Nucl Med; 2007 Jan; 48(1):94-9. PubMed ID: 17204704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of the global lumped constant for 2-deoxy-2-[18F]fluoro-D-glucose in normal human brain using [15O]water and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography imaging. A method with validation based on multiple methodologies.
    Wu HM; Bergsneider M; Glenn TC; Yeh E; Hovda DA; Phelps ME; Huang SC
    Mol Imaging Biol; 2003; 5(1):32-41. PubMed ID: 14499160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The (18)F-fluorodeoxyglucose lumped constant determined in human brain from extraction fractions of (18)F-fluorodeoxyglucose and glucose.
    Hasselbalch SG; Holm S; Pedersen HS; Svarer C; Knudsen GM; Madsen PL; Paulson OB
    J Cereb Blood Flow Metab; 2001 Aug; 21(8):995-1002. PubMed ID: 11487735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of regional blood-brain transport kinetics between glucose and fluorodeoxyglucose.
    Lear JL; Ackerman RF
    J Nucl Med; 1992 Oct; 33(10):1819-24. PubMed ID: 1403150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of cerebral glucose metabolic rates in the anesthetized rat by dynamic scanning with 18F-FDG, the ATLAS small animal PET scanner, and arterial blood sampling.
    Shimoji K; Ravasi L; Schmidt K; Soto-Montenegro ML; Esaki T; Seidel J; Jagoda E; Sokoloff L; Green MV; Eckelman WC
    J Nucl Med; 2004 Apr; 45(4):665-72. PubMed ID: 15073264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of the lumped constant for [18F] fluorodeoxyglucose in human skeletal muscle.
    Kelley DE; Williams KV; Price JC; Goodpaster B
    J Nucl Med; 1999 Nov; 40(11):1798-804. PubMed ID: 10565773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction for the effect of rising plasma glucose levels on quantification of MR(glc) with FDG-PET.
    Dunn JT; Anthony K; Amiel SA; Marsden PK
    J Cereb Blood Flow Metab; 2009 May; 29(5):1059-67. PubMed ID: 19293824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains.
    Ishii K; Willoch F; Minoshima S; Drzezga A; Ficaro EP; Cross DJ; Kuhl DE; Schwaiger M
    J Nucl Med; 2001 Apr; 42(4):548-57. PubMed ID: 11337540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multitracer study with positron emission tomography in Creutzfeldt-Jakob disease.
    Engler H; Lundberg PO; Ekbom K; Nennesmo I; Nilsson A; Bergström M; Tsukada H; Hartvig P; Långström B
    Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):85-95. PubMed ID: 12483414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whiskers area as extracerebral reference tissue for quantification of rat brain metabolism using (18)F-FDG PET: application to focal cerebral ischemia.
    Backes H; Walberer M; Endepols H; Neumaier B; Graf R; Wienhard K; Mies G
    J Nucl Med; 2011 Aug; 52(8):1252-60. PubMed ID: 21764786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRS glucose mapping and PET joining forces: re-evaluation of the lumped constant in the rat brain under isoflurane anaesthesia.
    Alf MF; Duarte JM; Lei H; Krämer SD; Mlynarik V; Schibli R; Gruetter R
    J Neurochem; 2014 May; 129(4):672-82. PubMed ID: 24471521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute changes in regional cerebral (18)F-FDG kinetics in patients with traumatic brain injury.
    Hattori N; Huang SC; Wu HM; Liao W; Glenn TC; Vespa PM; Phelps ME; Hovda DA; Bergsneider M
    J Nucl Med; 2004 May; 45(5):775-83. PubMed ID: 15136626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of cerebral glucose metabolic rate in mice using 18F-FDG and small-animal PET.
    Yu AS; Lin HD; Huang SC; Phelps ME; Wu HM
    J Nucl Med; 2009 Jun; 50(6):966-73. PubMed ID: 19443595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative regional analysis of 2-fluorodeoxyglucose and methylglucose uptake in brain of four stroke patients. With special reference to the regional estimation of the lumped constant.
    Gjedde A; Wienhard K; Heiss WD; Kloster G; Diemer NH; Herholz K; Pawlik G
    J Cereb Blood Flow Metab; 1985 Jun; 5(2):163-78. PubMed ID: 3872872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human adipose tissue glucose uptake determined using [(18)F]-fluoro-deoxy-glucose ([(18)F]FDG) and PET in combination with microdialysis.
    Virtanen KA; Peltoniemi P; Marjamäki P; Asola M; Strindberg L; Parkkola R; Huupponen R; Knuuti J; Lönnroth P; Nuutila P
    Diabetologia; 2001 Dec; 44(12):2171-9. PubMed ID: 11793018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron emission tomography with [(18)F]FDG in the diagnosis of Creutzfeldt-Jakob disease (CJD).
    Henkel K; Zerr I; Hertel A; Gratz KF; Schröter A; Tschampa HJ; Bihl H; Büll U; Grünwald F; Drzezga A; Spitz J; Poser S
    J Neurol; 2002 Jun; 249(6):699-705. PubMed ID: 12111302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET.
    Piert M; Koeppe RA; Giordani B; Berent S; Kuhl DE
    J Nucl Med; 1996 Feb; 37(2):201-8. PubMed ID: 8667045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.